Secondary prevention of upper gastrointestinal bleeding in low dose aspirin users infected with Helicobacter pylori

Medical Journal of the Islamic Republic of Iran

Volumn 19, Issue 1, 2005, Pages 35-36

  Dowlatshahi, Shahab ^a,b   Ghofrani, Hadi ^a,c   Togha, Mansoreh ^c   Dowlatshahi, Samaneh ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Department of Internal Medicine and Gastroenterology ^*  (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Helicobacter pylori; Low dose aspirin; Upper gastrointestinal bleeding

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; METRONIDAZOLE; OMEPRAZOLE;

ARTICLE; CONTROLLED STUDY; ENDOSCOPY; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; PROPHYLAXIS; SECONDARY PREVENTION; UPPER GASTROINTESTINAL BLEEDING;

EID: 33846255091     PISSN: 10161430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Weil J, Colin O, Langman M, et al: Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 310: 827-30, 1995.
2. Francis KI, et al: Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low dose aspirin. N Eng J Med 334: 967-973, 2001.
3. Aalykke C, Lauritsen JM, Hallas J, Reinholdt S, Lauritsen K: Helicobacter pylori and risk of ulcer bleeding among users of non-steroidal anti-inflammatory drugs: a case control study. Gastroenterology 116: 1305-9, 1999.
4. Garcia Rodriguez LA, Lick H: Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 343: 769, 1994.
5. Graham DY: Non-steroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand. Am J Gastroenterol 91: 2080-6, 1996.